Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03837522 · ClinicalTrials.gov registry record · NA
Trial to Define the Benefits and Harms of Deceased Donor Kidney Procurement Biopsies
A NA study, sponsored by St. Louis University.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT03837522: Completed NA study, sponsored by St. Louis University.
NCT03837522 is a NA study that has completed, run by St. Louis University. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03837522, a NA study, has completed, sponsored by St. Louis University.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this research study is to compare the impact of the availability of biopsy results at the time of organ offers on the use and outcomes of kidneys from deceased donors.
Primary Outcome
per kidney donor with an immediate vs delayed procurement biopsy processing (this will serve as the primary organ utilization metric, and is the adjusted converse of organ discard)
Interventions
- DIAGNOSTIC_TEST Procurement Biopsy: Frozen section
- DIAGNOSTIC_TEST Procurement Biopsy: Permanent section
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2019-09-17 |
| Est. Completion | 2023-02-04 |
| Phase | NA |
What the finished NCT03837522 record still lists
NCT03837522 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Procurement Biopsy: Frozen section is the first listed.
NCT03837522 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03837522 about?
NCT03837522 is a clinical study titled "Trial to Define the Benefits and Harms of Deceased Donor Kidney Procurement Biopsies". The purpose of this research study is to compare the impact of the availability of biopsy results at the time of organ offers on the use and outcomes of kidneys from deceased donors.
What is the current status of trial NCT03837522?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2019-09-17. Estimated completion is 2023-02-04.
What interventions are being tested in trial NCT03837522?
The interventions under investigation include: Procurement Biopsy: Frozen section (DIAGNOSTIC_TEST), Procurement Biopsy: Permanent section (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03837522?
This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03837522's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI